• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

远程医疗服务对二尖瓣和三尖瓣反流进展的影响:回顾性研究。

Effect of Telehealth Services on Mitral and Tricuspid Regurgitation Progression: Retrospective Study.

机构信息

Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.

出版信息

J Med Internet Res. 2023 Sep 26;25:e47947. doi: 10.2196/47947.

DOI:10.2196/47947
PMID:37751276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10565617/
Abstract

BACKGROUND

Mitral regurgitation (MR) and tricuspid regurgitation (TR) are common cardiac conditions with high mortality risks, which can be improved through early intervention. Telehealth services, which allow for remote monitoring of patient conditions, have been proven to improve the health management of chronic diseases, but the effects on MR and TR progression are unknown.

OBJECTIVE

This study aimed to explore whether patients receiving telehealth services have less MR and TR progression compared with a control group. We also aimed to identify the determinants of MR and TR progression.

METHODS

This single-center retrospective study conducted at the National Taiwan University Hospital compared MR and TR progression (defined as either progression to moderate or greater MR and TR or MR and TR progression by ≥2 grades during the study period) between the telehealth and control groups. Patients had a minimum of 2 transthoracic echocardiograms at least 6 months apart; baseline mild-moderate MR and TR or lower; and no prior surgeries on the mitral or tricuspid valve. Telehealth patients were defined as those who received telehealth services for at least 28 days within 3 months of baseline. Basic demographics, baseline blood pressure measurements, prescribed medication, and Charlson Comorbidity Index components were obtained for all patients.

RESULTS

A total of 1081 patients (n=226 in the telehealth group and n=855 in the control group) were included in the study analyses. The telehealth group showed significantly lower baseline systolic blood pressure (P<.001), higher Charlson Comorbidity Index (P=.02), higher prevalence of prior myocardial infarction (P=.01) and heart failure (P<.001), higher beta-blocker (P=.03) and diuretic (P=.04) use, and lower nitrate use (P=.04). Both groups showed similar cardiac remodeling conditions at baseline. Telehealth was found to be neutral for both MR (hazard ratio 1.10, 95% CI 0.80-1.52; P=.52) and TR (hazard ratio 1.27, 95% CI 0.92-1.74; P=.14) progression. Determinants for moderate or greater MR progression included older age, female sex, diuretic use, larger left atrial dimension, left ventricular end-diastolic dimension, left ventricular end-systolic dimension, and lower left ventricular ejection fraction. Determinants of moderate or greater TR progression included older age, female sex, diuretic use, presence of atrial fibrillation, LA dimension, left ventricular end-systolic dimension, and lower left ventricular ejection fraction; statin use was found to be protective.

CONCLUSIONS

This is the first study to assess the association between telehealth services and the progression of MR and TR. Telehealth patients, who had more comorbidities, displayed similar MR and TR progression versus control patients, indicating that telehealth may slow MR and TR progression. Determinants of MR and TR progression included easy-to-measure traditional echo parameters of cardiac function, older age, female sex, and atrial fibrillation, which can be incorporated into a telehealth platform and advanced alert system, improving patient outcomes through personalized care.

摘要

背景

二尖瓣反流(MR)和三尖瓣反流(TR)是常见的心脏疾病,具有较高的死亡率风险,早期干预可改善其预后。远程医疗服务可以对患者病情进行远程监测,已被证明可改善慢性病的健康管理,但对于 MR 和 TR 进展的影响尚不清楚。

目的

本研究旨在探讨接受远程医疗服务的患者与对照组相比,MR 和 TR 进展是否更少。我们还旨在确定 MR 和 TR 进展的决定因素。

方法

这项在国立台湾大学医院进行的单中心回顾性研究比较了远程医疗组和对照组之间的 MR 和 TR 进展(定义为研究期间进展为中度或更严重的 MR 和 TR 或 MR 和 TR 进展≥2 级)。患者至少有 2 次至少间隔 6 个月的经胸超声心动图检查;基线轻度至中度 MR 和 TR 或更低;且二尖瓣或三尖瓣无既往手术史。远程医疗患者被定义为在基线后 3 个月内至少接受了 28 天远程医疗服务的患者。所有患者均获得了基本人口统计学资料、基线血压测量值、处方药物和 Charlson 合并症指数成分。

结果

共纳入 1081 例患者(远程医疗组 226 例,对照组 855 例)进行研究分析。远程医疗组的基线收缩压明显较低(P<.001),Charlson 合并症指数较高(P=.02),既往心肌梗死(P=.01)和心力衰竭(P<.001)的患病率较高,β受体阻滞剂(P=.03)和利尿剂(P=.04)的使用率较高,硝酸盐的使用率较低(P=.04)。两组患者的基线心脏重构情况相似。远程医疗对 MR(风险比 1.10,95%置信区间 0.80-1.52;P=.52)和 TR(风险比 1.27,95%置信区间 0.92-1.74;P=.14)进展均无影响。中度或更严重的 MR 进展的决定因素包括年龄较大、女性、利尿剂使用、左心房内径较大、左心室舒张末期内径、左心室收缩末期内径和左心室射血分数较低。中度或更严重的 TR 进展的决定因素包括年龄较大、女性、利尿剂使用、心房颤动、左心房内径、左心室收缩末期内径和左心室射血分数较低;他汀类药物的使用被认为具有保护作用。

结论

这是第一项评估远程医疗服务与 MR 和 TR 进展之间关联的研究。远程医疗组患者合并症更多,与对照组患者相比,MR 和 TR 进展情况相似,表明远程医疗可能会减缓 MR 和 TR 的进展。MR 和 TR 进展的决定因素包括心脏功能的易于测量的传统超声心动图参数、年龄较大、女性和心房颤动,这些因素可以纳入远程医疗平台和高级预警系统,通过个性化护理改善患者预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3825/10565617/3a2ffdadd5f2/jmir_v25i1e47947_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3825/10565617/3a2ffdadd5f2/jmir_v25i1e47947_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3825/10565617/3a2ffdadd5f2/jmir_v25i1e47947_fig1.jpg

相似文献

1
Effect of Telehealth Services on Mitral and Tricuspid Regurgitation Progression: Retrospective Study.远程医疗服务对二尖瓣和三尖瓣反流进展的影响:回顾性研究。
J Med Internet Res. 2023 Sep 26;25:e47947. doi: 10.2196/47947.
2
Prevalence and Prognostic Significance of Functional Mitral and Tricuspid Regurgitation Despite Preserved Left Ventricular Ejection Fraction in Atrial Fibrillation Patients.尽管在房颤患者中左心室射血分数正常,但功能性二尖瓣和三尖瓣反流的患病率及其预后意义。
Circ J. 2018 Apr 25;82(5):1451-1458. doi: 10.1253/circj.CJ-17-1334. Epub 2018 Mar 16.
3
Tricuspid regurgitation in patients with severe mitral regurgitation and normal left ventricular ejection fraction: risk factors and prognostic implications in a cohort of 895 patients.重度二尖瓣反流且左心室射血分数正常患者的三尖瓣反流:895例患者队列中的危险因素及预后意义
J Heart Valve Dis. 2010 Jul;19(4):412-9.
4
Mitral Valve Prolapse Patients with Less than Moderate Mitral Regurgitation Exhibit Early Cardiac Chamber Remodeling.二尖瓣脱垂伴轻度以下二尖瓣反流患者存在早期心腔重构。
J Am Soc Echocardiogr. 2020 Jul;33(7):815-825.e2. doi: 10.1016/j.echo.2020.01.016. Epub 2020 Mar 26.
5
Concomitant Mitral Regurgitation in Patients With Chronic Aortic Regurgitation.慢性主动脉瓣反流患者合并二尖瓣反流。
J Am Coll Cardiol. 2020 Jul 21;76(3):233-246. doi: 10.1016/j.jacc.2020.05.051.
6
Functional Tricuspid Regurgitation Caused by Chronic Atrial Fibrillation: A Real-Time 3-Dimensional Transesophageal Echocardiography Study.慢性心房颤动所致功能性三尖瓣反流:一项实时三维经食管超声心动图研究
Circ Cardiovasc Imaging. 2017 Jan;10(1). doi: 10.1161/CIRCIMAGING.116.004897.
7
Successful surgical treatment of chronic ischemic mitral regurgitation achieves left ventricular reverse remodeling but does not affect right ventricular function.慢性缺血性二尖瓣反流的成功外科治疗可实现左心室逆向重构,但不影响右心室功能。
J Thorac Cardiovasc Surg. 2009 Aug;138(2):341-51. doi: 10.1016/j.jtcvs.2008.12.034.
8
Significant functional tricuspid regurgitation portends poor outcomes in patients with atrial fibrillation and preserved left ventricular ejection fraction.伴有左心室射血分数保留的房颤患者中,重度三尖瓣反流预示着不良结局。
BMC Cardiovasc Disord. 2020 Oct 6;20(1):433. doi: 10.1186/s12872-020-01716-6.
9
Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction.左心室收缩功能障碍患者中二尖瓣反流和三尖瓣反流的预后意义
Am Heart J. 2002 Sep;144(3):524-9. doi: 10.1067/mhj.2002.123575.
10
Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation.缺血性二尖瓣反流手术后三尖瓣反流的进展。
J Am Coll Cardiol. 2021 Feb 16;77(6):713-724. doi: 10.1016/j.jacc.2020.11.066.

引用本文的文献

1
Effects of a Cloud-Based Synchronous Telehealth Program on Valvular Regurgitation Regression: Retrospective Study.基于云的同步远程医疗计划对瓣膜反流消退的影响:回顾性研究。
J Med Internet Res. 2025 Apr 23;27:e68929. doi: 10.2196/68929.

本文引用的文献

1
Predictors of Progression of Tricuspid Regurgitation in Patients with Persistent Atrial Fibrillation.持续性心房颤动患者三尖瓣反流进展的预测因素
Chonnam Med J. 2023 Jan;59(1):70-75. doi: 10.4068/cmj.2023.59.1.70. Epub 2023 Jan 25.
2
Novice-performed point-of-care ultrasound for home-based imaging.新手在家庭环境中进行即时超声检查。
Sci Rep. 2022 Nov 28;12(1):20461. doi: 10.1038/s41598-022-24513-x.
3
Progression of Mitral Regurgitation in Rheumatic Valve Disease: Role of Left Atrial Remodeling.风湿性瓣膜病中二尖瓣反流的进展:左心房重塑的作用。
Front Cardiovasc Med. 2022 Mar 11;9:862382. doi: 10.3389/fcvm.2022.862382. eCollection 2022.
4
Clinical Predictors of Mortality in Patients with Moderate to Severe Mitral Regurgitation.中重度二尖瓣反流患者死亡率的临床预测因素
Am J Med. 2022 Mar;135(3):380-385.e3. doi: 10.1016/j.amjmed.2021.09.004. Epub 2021 Oct 12.
5
Utility of a Deep-Learning Algorithm to Guide Novices to Acquire Echocardiograms for Limited Diagnostic Use.深度学习算法在指导新手获取有限诊断用途的超声心动图中的应用。
JAMA Cardiol. 2021 Jun 1;6(6):624-632. doi: 10.1001/jamacardio.2021.0185.
6
Natural course of tricuspid regurgitation and prognostic implications.三尖瓣反流的自然病程及预后意义。
Open Heart. 2021 Feb;8(1). doi: 10.1136/openhrt-2020-001529.
7
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020美国心脏病学会/美国心脏协会瓣膜性心脏病患者管理指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2021 Feb 2;143(5):e72-e227. doi: 10.1161/CIR.0000000000000923. Epub 2020 Dec 17.
8
Home Monitoring of Cardiac Devices in the Era of COVID-19.COVID-19 时期的心脏设备家庭监测。
Curr Cardiol Rep. 2020 Nov 20;23(1):1. doi: 10.1007/s11886-020-01431-w.
9
Sex-Related Differences in the Mechanism of Functional Tricuspid Regurgitation.性功能三尖瓣反流的机制中的性别差异。
Heart Lung Circ. 2021 Jan;30(1):e16-e22. doi: 10.1016/j.hlc.2020.06.018. Epub 2020 Jul 27.
10
Handheld Point-of-Care Ultrasound Probes: The New Generation of POCUS.手持式即时超声探头:POCUS 的新一代产品。
J Cardiothorac Vasc Anesth. 2020 Nov;34(11):3139-3145. doi: 10.1053/j.jvca.2020.07.004. Epub 2020 Jul 7.